Several physiological and pathophysiological stimuli or drugs modulate endothelial progenitor cell (EPC) mobilization. Moreover, levels of circulating EPCs predict cardiovascular risk and left ventricular remodelling after myocardial infarction. Nevertheless, our understanding in this field is complicated by lack of an unequivocal definition of EPCs, thus limiting their clinical applications. This review summarizes current knowledge and uncertainties on EPC characterization and mobilization in the attempt to define their role in the management of cardiovascular diseases.
From bone marrow to the arterial wall: The ongoing tale of endothelial progenitor cells / Leone, A. M.; Valgimigli, M.; Giannico, M. B.; Zaccone, V.; Perfetti, M.; D'Amario, D.; Rebuzzi, A. G.; Crea, F.. - In: EUROPEAN HEART JOURNAL. - ISSN 0195-668X. - 30:8(2009), pp. 890-899. [10.1093/eurheartj/ehp078]
From bone marrow to the arterial wall: The ongoing tale of endothelial progenitor cells
Zaccone V.;
2009-01-01
Abstract
Several physiological and pathophysiological stimuli or drugs modulate endothelial progenitor cell (EPC) mobilization. Moreover, levels of circulating EPCs predict cardiovascular risk and left ventricular remodelling after myocardial infarction. Nevertheless, our understanding in this field is complicated by lack of an unequivocal definition of EPCs, thus limiting their clinical applications. This review summarizes current knowledge and uncertainties on EPC characterization and mobilization in the attempt to define their role in the management of cardiovascular diseases.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
